To speculate, our 6GPS may show predictive potential for cancer therapies, particularly for compounds acting through anti-proliferative mechanisms, like CDK-, Aurora kinase, or RAF/MEK/mTOR inhibitors. This evidence concerns the gene MAP2K7 and cancer.